Original Article

Care Pathway at a Cancer Center for the Administration of Radiometabolic Therapy with 177Lu-PSMA in Patients with Metastatic Castration-resistant Prostate Cancer
  • Carlos Avila
  • Tatiana Cadavid
  • Maria Cristina Martínez
  • Humberto Varela
  • Nathalie Hernández-Hidalgo
Mol Imaging Radionucl Ther 2024; 33: 28-37 DOI: 10.4274/mirt.galenos.2023.82653 PMID:38390762
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry
  • Levent Kabasakal
  • Türkay Toklu
  • Nami Yeyin
  • Emre Demirci
  • Mohammad Abuqbeitah
  • Meltem Ocak
  • Aslan Aygün
  • Emre Karayel
  • Hüseyin Pehlivanoglu
  • Nalan Alan Selçuk
Mol Imaging Radionucl Ther 2017; 26: 62-68 DOI: 10.4274/mirt.08760 PMID:28613198